The pharmacokinetics of subcutaneous G-CSF in healthy donors and cancer patients show a maximum serum concentration within 2 ± 8 h, and due to the short elimination half-life of G-CSF (approximately 3 ± 4 h), thus a twice-daily schedule may improve CD34+cell yield.27 Here, CSF3 is linked to cancer.